Actemra Archives -

Olumiant benefits additive to other drugs in severe COVID patients

Phil Taylor Actemra, coronavirus, COVID-19, Eli Lilly, Gilead Sciences, Incyte, JAK inhibitor, Olumiant, Roche, Veklury 0 Comment

Eli Lilly and Incyte’s JAK inhibitor Olumiant reduced the risk of death by 13% in hospitalised COVID-19 patients

Olumiant benefits additive to other drugs in severe COVID patients

https://pharmaphorum.com/news/olumiant-benefits-additive-to-other-drugs-in-severe-covid-patients/

Market Access/ News/ News

EU approves Roche’s Actemra for severe COVID-19

Phil Taylor Actemra, coronavirus, COVID-19, European Commission, regulatory approval, Roche 0 Comment

The European Commission has moved swiftly to grant full approval to Roche’s Actemra/RoActemra as a treatment for severe

EU approves Roche’s Actemra for severe COVID-19

https://pharmaphorum.com/news/eu-approves-roches-actemra-for-covid-19/

News/ News/ Sales and Marketing

Actemra shortage spills over to include Sanofi’s rival Kevzara

Phil Taylor Actemra, coronavirus, COVID-19, drug shortages, Kevzara, Rheumatoid arthritis, Roche, Sanofi 0 Comment

Roche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to

Actemra shortage spills over to include Sanofi’s rival Kevzara

https://pharmaphorum.com/news/actemra-shortage-spills-over-to-include-sanofis-rival-kevzara/

Market Access/ News/ News

Amid Actemra shortage, WHO asks Roche to ensure equitable access

Phil Taylor Actemra, coronavirus, COVID-19, drug shortages, Genentech, Roche 0 Comment

Roche’s arthritis drug Actemra has become a key treatment for people with severe COVID-19, leading to shortages, and

Amid Actemra shortage, WHO asks Roche to ensure equitable access

https://pharmaphorum.com/news/amid-actemra-shortage-who-asks-roche-to-ensure-equitable-access/

News/ News/ Patients

FDA gives Roche’s Actemra emergency okay for severe COVID

Phil Taylor Actemra, coronavirus, COVID-19, fda, Roche 0 Comment

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for

FDA gives Roche’s Actemra emergency okay for severe COVID

https://pharmaphorum.com/news/fda-gives-roches-actemra-emergency-okay-for-severe-covid/

News/ News/ Patients

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

Phil Taylor Actemra, coronavirus, COVID-19, Kevzara, NHS, Roche, Sanofi, UK 0 Comment

New data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

https://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/

News/ News/ R&D

Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

Richard Staines Actemra, coronavirus, COVID-19, Roche, Sanofi 0 Comment

Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances

Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

https://pharmaphorum.com/news/roche-actemra-cuts-chances-of-covid-19/

News/ News/ R&D

Setback in COVID-19 effort as Roche’s Actemra fails in key trial

Richard Staines Actemra, coronavirus, COVID-19, Roche 0 Comment

Roche’s anti-inflammatory drug Actemra has failed in a phase 3 clinical trial that was testing to see if

Setback in COVID-19 effort as Roche’s Actemra fails in key trial

https://pharmaphorum.com/news/setback-in-covid-19-effort-as-roches-actemra-fails-in-key-trial/

News/ News/ Sales and Marketing/ Top stories

COVID-19 candidate Actemra helps Roche to solid first quarter

Phil Taylor Actemra, coronavirus, Financial, Roche 0 Comment

Roche shrugged off the impact of the coronavirus pandemic in the first-quarter with good sales growth across its

COVID-19 candidate Actemra helps Roche to solid first quarter

https://pharmaphorum.com/news/covid-19-candidate-actemra-helps-roche-to-solid-first-quarter/

Trending

Actemra

Login